InvestorsHub Logo
Followers 28
Posts 1829
Boards Moderated 0
Alias Born 08/25/2015

Re: XenaLives post# 189100

Tuesday, 04/09/2019 11:12:59 PM

Tuesday, April 09, 2019 11:12:59 PM

Post# of 458888
My bad, it wasn’t in the title. There were follow up articles from 3rd parties covering the story which included the 400% better then soc - which I was unable to find.

Here is the link to the 5 wk data I referenced:

https://www.anavex.com/anavex-presents-positive-initial-phase-2a-study-data-with-anavex-2-73-showing-early-evidence-of-improving-cognition-in-patients-with-alzheimers-disease-at-aaic-2015/

Here is the quote I was referencing from the PR, touting 2-73’s efficacy (400% better then soc):

“At day 36, the amplitude of the cognitive EEG/ERP biomarker P300 increased 38 percent from baseline. Published data suggests that a 38 percent increase is approximately 4 times higher than donepezil (Aricept®), the current standard of care, in the same timeframe.”



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News